Literature DB >> 1652022

3-Thienyl- and 3-furylaminobutyric acids. Synthesis and binding GABAB receptor studies.

P Berthelot1, C Vaccher, N Flouquet, M Debaert, M Luyckx, C Brunet.   

Abstract

Baclofen (beta-(p-chlorophenyl)-GABA) is a selective agonist for the bicuculline-insensitive GABAB receptor. The search for new compounds that bind to the GABAB receptor is very important to clarify structural requirements. We report herein the synthesis and the binding studies of variously substituted 3-thienyl- and 3-furylaminobutyric acids. 4-Amino-3-(5-methyl-2-thienyl)butyric acid (5d) and 4-amino-3-(5-chloro-2-thienyl)butyric acid (5h) are potent and specific ligands for GABAB receptor. The IC50 values for the displacement of (R)-(-)-[3H]baclofen are 1.34 and 0.61 microM for 5d and 5h, respectively, as compared to 0.33 microM for baclofen.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1652022     DOI: 10.1021/jm00112a033

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Molecular modelling and conformational analysis of a GABAB antagonist.

Authors:  B Pirard; F Durant
Journal:  J Comput Aided Mol Des       Date:  1996-02       Impact factor: 3.686

2.  Functional pharmacology of cloned heterodimeric GABAB receptors expressed in mammalian cells.

Authors:  H Bräuner-Osborne; P Krogsgaard-Larsen
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

3.  Direct β-selectivity of α,β-unsaturated γ-butyrolactam for asymmetric conjugate additions in an organocatalytic manner.

Authors:  Yuan Zhong; Sihua Hong; Zhengjun Cai; Shixiong Ma; Xianxing Jiang
Journal:  RSC Adv       Date:  2018-08-14       Impact factor: 4.036

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.